Bath & Body Works, Inc. (NYSE:BBWI) Shares Purchased by Fuller & Thaler Asset Management Inc.

Fuller & Thaler Asset Management Inc. raised its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 28.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,706,425 shares of the company's stock after acquiring an additional 377,892 shares during the period. Fuller & Thaler Asset Management Inc. owned approximately 0.79% of Bath & Body Works worth $66,158,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Fifth Third Wealth Advisors LLC boosted its holdings in Bath & Body Works by 4.9% during the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company's stock valued at $271,000 after acquiring an additional 324 shares during the period. SRS Capital Advisors Inc. lifted its position in shares of Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after purchasing an additional 329 shares in the last quarter. UMB Bank n.a. boosted its stake in shares of Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after purchasing an additional 335 shares during the period. Lindbrook Capital LLC grew its holdings in shares of Bath & Body Works by 81.9% in the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after purchasing an additional 431 shares in the last quarter. Finally, Cornerstone Investment Partners LLC increased its stake in Bath & Body Works by 3.8% during the 4th quarter. Cornerstone Investment Partners LLC now owns 12,248 shares of the company's stock worth $475,000 after buying an additional 452 shares during the period. 95.14% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have commented on BBWI shares. Citigroup decreased their price target on shares of Bath & Body Works from $48.00 to $36.00 and set a "buy" rating for the company in a research report on Monday, April 7th. Wells Fargo & Company upgraded Bath & Body Works from an "equal weight" rating to an "overweight" rating and lifted their target price for the company from $42.00 to $48.00 in a report on Friday, January 10th. Telsey Advisory Group restated an "outperform" rating and set a $43.00 price target on shares of Bath & Body Works in a report on Thursday, February 27th. Raymond James decreased their price objective on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a research note on Thursday, April 17th. Finally, Cowen reissued a "buy" rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Four analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $42.69.

Bath & Body Works Price Performance

Shares of BBWI traded down $0.14 during midday trading on Friday, reaching $29.61. 3,024,953 shares of the stock were exchanged, compared to its average volume of 4,790,661. Bath & Body Works, Inc. has a twelve month low of $24.96 and a twelve month high of $52.99. The company has a market capitalization of $6.34 billion, a price-to-earnings ratio of 7.22, a PEG ratio of 0.92 and a beta of 1.69. The business's 50-day moving average price is $31.33 and its 200 day moving average price is $33.84.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, equities research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works announced that its Board of Directors has approved a share repurchase plan on Thursday, February 27th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to repurchase up to 6.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's board believes its shares are undervalued.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.70%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works's payout ratio is currently 21.98%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.